CERAMICSGRES LTD

Financial Health Assessment: CERAMICSGRES LTD

1. Financial Health Score: D-

Explanation: The patient has survived a massive financial hemorrhage but is left in a severely weakened state. While the company is technically still breathing (solvent), it experienced a catastrophic 97% drop in net assets in a single year, falling from a robust £303,009 in 2024 to a fragile £8,561 in 2025. Unless this was a planned, healthy extraction of wealth by the owner, the business's immune system (cash reserves) has been critically compromised, leaving it highly vulnerable to even minor financial shocks.

2. Key Vital Signs

• Net Assets (Patient's Weight): £8,561 (Down from £303,009)
  • Interpretation: Severe, sudden weight loss. Net assets represent the company's overall value after paying off all debts. The drastic drop indicates that the business has either suffered enormous trading losses or the owner has extracted the vast majority of the company's value.
• Current Assets (Blood Flow): £27,170 (Down from £322,656)
  • Interpretation: The blood flow has slowed to a trickle. Current assets (cash, stock, money owed by customers) are the fuel that keeps the heart pumping on a day-to-day basis. With only £27k remaining, the business has very little liquidity to fund its operations.
• Current Liabilities (Toxins): £18,609 (Slightly down from £19,647)
  • Interpretation: Toxin levels remain stable but are now disproportionately high compared to the remaining blood flow. The company owes nearly £19k, which is manageable, but the margin for error has vanished.
• Current Ratio (Pulse): 1.46 (£27,170 / £18,609)
  • Interpretation: The pulse is faint but present. A current ratio of 1.46 means the company has £1.46 in short-term assets for every £1 of short-term debt. While technically "healthy" by textbook standards, this ratio masks the fact that the underlying asset base has shrunk to almost nothing. A single unpaid invoice could push this ratio below 1, leading to insolvency.
• Employees (Metabolic Rate): 0
  • Interpretation: The business is operating with no metabolic overhead. As a wholesale company with zero employees, it is likely operating as a shell, relying entirely on the director's efforts or acting as a passive vehicle.

3. Diagnosis: Acute Capital Depletion

The financial data reveals a business that has experienced an acute hemorrhage of capital. For years (2016-2024), CERAMICSGRES LTD exhibited steady, healthy growth, accumulating over £300k in net worth. Suddenly, in the 2025 fiscal year, nearly all of that accumulated wealth vanished.

There are two primary differential diagnoses for this symptom:

1. Planned Extraction (Dividend/Capital Distribution): As a micro-entity wholly owned by a single director (Xxxxxx Xxxxxxxxname shown to subscribers), it is highly possible that the director simply decided to extract the accumulated profits as a dividend. In medical terms, this is like a controlled blood donation—the patient intentionally depleted their reserves, which is excellent for the owner's personal wealth but leaves the corporate entity anemic.
2. Catastrophic Trading Loss: The alternative is that the business suffered a massive loss—perhaps writing off bad stock, losing a major client, or making a severe operational miscalculation. If this is the case, the business is in critical condition.

Because the company files as a "Micro-entity," it is exempt from filing a Profit & Loss account, meaning we cannot see the exact cause of the bleed. However, the stability of the liabilities suggests the company did not take on massive new debts, making the "planned extraction" diagnosis much more likely than a trading catastrophe.

Regardless of the cause, the corporate body itself is now severely underweight and immunocompromised. It lacks the financial reserves to weather a storm.

4. Recommendations: Treatment Plan

To restore financial wellness and protect the company from future distress, the following actions are recommended:

• Identify the Source of the Bleed: The director must clearly document the cause of the £294k drop in net assets. If it was a dividend, ensure that proper paperwork and tax filings (including the upcoming Corporation Tax return) reflect this distribution. If it was a capital reduction, ensure legal formalities were followed.
• Financial Triage (Cash Flow Monitoring): With only £8,561 separating the company from insolvency, cash flow must be monitored on a weekly, if not daily, basis. Do not take on any new financial commitments or long-term liabilities without securing corresponding cash flow.
• Stabilize the Patient (Build Reserves): If the business intends to continue trading, it must be refed. Profit margins on future wholesale deals should be retained within the business to rebuild a healthy net asset buffer. Aim to rebuild net assets to at least 3 months of operating expenses.
• Assess Quality of Life (Going Concern): If the director extracted the funds because the business is no longer actively trading, it may be time to consider putting the patient to sleep. If the company is dormant or no longer serving a purpose, striking it off the register would save on annual compliance and administrative costs.

Names of the people mentioned are shown to subscribers. See subscription